
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $403.4M | $630.5M | $695.7M | $566.5M | $508.5M | |
Revenue Growth (YoY) | 26.86% | 56.29% | 10.35% | -18.58% | -10.23% | |
Cost of Revenues | $260.6M | $426.3M | $479.3M | $413.5M | $354.8M | |
Gross Profit | $142.8M | $204.2M | $216.5M | $152.9M | $153.7M | |
Gross Profit Margin | 35.39% | 32.38% | 31.11% | 27% | 30.23% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $85.5M | $217.8M | $146.8M | $110.3M | $108.4M | |
Other Inc / (Exp) | $1.1M | $7.1M | -$536K | $4.7M | -$2.2M | |
Operating Expenses | $102.9M | $240.3M | $186.5M | $136.8M | $135.5M | |
Operating Income | $39.9M | -$36.2M | $30M | $16.1M | $18.3M | |
Net Interest Expenses | $18.3M | $24.4M | $15.8M | $30.9M | $24.8M | |
EBT. Incl. Unusual Items | $22.8M | -$53.5M | $13.7M | -$10.1M | -$8.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $6.8M | $8.8M | $19.4M | -$7.7M | $9.1M | |
Net Income to Company | $16M | -$62.3M | -$5.7M | -$2.4M | -$17.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $16M | -$62.3M | -$5.7M | -$2.4M | -$17.9M | |
Basic EPS (Cont. Ops) | $0.13 | -$0.56 | -$0.05 | -$0.02 | -$0.15 | |
Diluted EPS (Cont. Ops) | $0.13 | -$0.56 | -$0.05 | -$0.02 | -$0.15 | |
Weighted Average Basic Share | $122M | $110.6M | $113.2M | $112.9M | $115.4M | |
Weighted Average Diluted Share | $122M | $110.6M | $113.2M | $112.9M | $115.4M | |
EBITDA | $66.4M | $3.1M | $67.6M | $61.6M | $60.5M | |
EBIT | $41M | -$29.1M | $29.5M | $20.9M | $16.1M | |
Revenue (Reported) | $403.4M | $630.5M | $695.7M | $566.5M | $508.5M | |
Operating Income (Reported) | $39.9M | -$36.2M | $30M | $16.1M | $18.3M | |
Operating Income (Adjusted) | $41M | -$29.1M | $29.5M | $20.9M | $16.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $148.7M | $191.6M | $137.7M | $110.6M | $111.4M | |
Revenue Growth (YoY) | 190.9% | 28.82% | -28.13% | -19.67% | 0.72% | |
Cost of Revenues | $96.3M | $121M | $104.3M | $80M | $78.5M | |
Gross Profit | $52.4M | $70.7M | $33.4M | $30.6M | $32.9M | |
Gross Profit Margin | 35.26% | 36.87% | 24.23% | 27.65% | 29.51% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $27.2M | $45.2M | $33.1M | $26.3M | $30.6M | |
Other Inc / (Exp) | $799K | -$2.6M | -$173K | -$277K | $1.3M | |
Operating Expenses | $32.8M | $63.9M | $39.7M | $32.7M | $37.8M | |
Operating Income | $19.7M | $6.8M | -$6.3M | -$2.1M | -$4.9M | |
Net Interest Expenses | $9.1M | $1.8M | $10.8M | $5M | $6.4M | |
EBT. Incl. Unusual Items | $11.4M | $2.5M | -$17.3M | -$7.3M | -$10M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.9M | $5.3M | -$2.9M | $532K | -$4.1M | |
Net Income to Company | $8.5M | -$2.8M | -$14.4M | -$7.9M | -$6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $8.5M | -$2.8M | -$14.4M | -$7.9M | -$6M | |
Basic EPS (Cont. Ops) | $0.07 | -$0.02 | -$0.13 | -$0.07 | -$0.05 | |
Diluted EPS (Cont. Ops) | $0.07 | -$0.02 | -$0.13 | -$0.07 | -$0.05 | |
Weighted Average Basic Share | $120.4M | $113.7M | $112.1M | $115M | $115.9M | |
Weighted Average Diluted Share | $120.4M | $113.7M | $112.1M | $115M | $115.9M | |
EBITDA | $28.4M | $13.7M | $2.8M | $8M | $8.7M | |
EBIT | $20.5M | $4.2M | -$6.5M | -$2.4M | -$3.7M | |
Revenue (Reported) | $148.7M | $191.6M | $137.7M | $110.6M | $111.4M | |
Operating Income (Reported) | $19.7M | $6.8M | -$6.3M | -$2.1M | -$4.9M | |
Operating Income (Adjusted) | $20.5M | $4.2M | -$6.5M | -$2.4M | -$3.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $501M | $673.3M | $641.8M | $539.4M | $509.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $315.9M | $450.9M | $462.7M | $389.2M | $353.3M | |
Gross Profit | $185.1M | $222.4M | $179.2M | $150.2M | $156M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $97.3M | $235.8M | $134.7M | $103.5M | $112.7M | |
Other Inc / (Exp) | $5.7M | $3.7M | $1.9M | $4.6M | -$639K | |
Operating Expenses | $116.1M | $271.4M | $162.3M | $129.8M | $140.6M | |
Operating Income | $69M | -$49.1M | $16.9M | $20.4M | $15.4M | |
Net Interest Expenses | $22M | $17.1M | $24.8M | $25.1M | $26.2M | |
EBT. Incl. Unusual Items | $52.6M | -$62.5M | -$6M | -$96K | -$11.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12.7M | $11.2M | $11.2M | -$4.2M | $4.5M | |
Net Income to Company | $40M | -$73.7M | -$17.2M | $4.1M | -$16M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $40M | -$73.7M | -$17.2M | $4.1M | -$16M | |
Basic EPS (Cont. Ops) | $0.33 | -$0.66 | -$0.16 | $0.03 | -$0.13 | |
Diluted EPS (Cont. Ops) | $0.33 | -$0.66 | -$0.16 | $0.03 | -$0.14 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $101.7M | -$11.5M | $56.7M | $66.9M | $61.3M | |
EBIT | $74.2M | -$45.3M | $18.8M | $25M | $14.8M | |
Revenue (Reported) | $501M | $673.3M | $641.8M | $539.4M | $509.3M | |
Operating Income (Reported) | $69M | -$49.1M | $16.9M | $20.4M | $15.4M | |
Operating Income (Adjusted) | $74.2M | -$45.3M | $18.8M | $25M | $14.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $148.7M | $191.6M | $137.7M | $110.6M | $111.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $96.3M | $121M | $104.3M | $80M | $78.5M | |
Gross Profit | $52.4M | $70.7M | $33.4M | $30.6M | $32.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $27.2M | $45.2M | $33.1M | $26.3M | $30.6M | |
Other Inc / (Exp) | $799K | -$2.6M | -$173K | -$277K | $1.3M | |
Operating Expenses | $32.8M | $63.9M | $39.7M | $32.7M | $37.8M | |
Operating Income | $19.7M | $6.8M | -$6.3M | -$2.1M | -$4.9M | |
Net Interest Expenses | $9.1M | $1.8M | $10.8M | $5M | $6.4M | |
EBT. Incl. Unusual Items | $11.4M | $2.5M | -$17.3M | -$7.3M | -$10M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.9M | $5.3M | -$2.9M | $532K | -$4.1M | |
Net Income to Company | $8.5M | -$2.8M | -$14.4M | -$7.9M | -$6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $8.5M | -$2.8M | -$14.4M | -$7.9M | -$6M | |
Basic EPS (Cont. Ops) | $0.07 | -$0.02 | -$0.13 | -$0.07 | -$0.05 | |
Diluted EPS (Cont. Ops) | $0.07 | -$0.02 | -$0.13 | -$0.07 | -$0.05 | |
Weighted Average Basic Share | $120.4M | $113.7M | $112.1M | $115M | $115.9M | |
Weighted Average Diluted Share | $120.4M | $113.7M | $112.1M | $115M | $115.9M | |
EBITDA | $28.4M | $13.7M | $2.8M | $8M | $8.7M | |
EBIT | $20.5M | $4.2M | -$6.5M | -$2.4M | -$3.7M | |
Revenue (Reported) | $148.7M | $191.6M | $137.7M | $110.6M | $111.4M | |
Operating Income (Reported) | $19.7M | $6.8M | -$6.3M | -$2.1M | -$4.9M | |
Operating Income (Adjusted) | $20.5M | $4.2M | -$6.5M | -$2.4M | -$3.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $59.3M | $44M | $32.6M | $102.8M | $56.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $32.8M | $60.8M | $48.8M | $30.4M | $32.3M | |
Inventory | $64.8M | $109.6M | $165.2M | $97.1M | $77.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $6.1M | $10.8M | $6M | $7.3M | $8.5M | |
Total Current Assets | $167.3M | $229.1M | $255M | $238.6M | $178.3M | |
Property Plant And Equipment | $47.4M | $63.5M | $136.5M | $143.8M | $141.1M | |
Long-Term Investments | $25.4M | $23.4M | $25.1M | $25.9M | $24.9M | |
Goodwill | $115.8M | $128.9M | $131.4M | $131.4M | $152.6M | |
Other Intangibles | $289.5M | $338.3M | $309.2M | $282.8M | $292.9M | |
Other Long-Term Assets | -- | $765K | $4.7M | $5M | $3.6M | |
Total Assets | $646.7M | $794.5M | $869.7M | $835M | $794.2M | |
Accounts Payable | $26.9M | $38M | $25.4M | $17.1M | $13.1M | |
Accrued Expenses | $38.8M | $47.9M | $41.7M | $32.3M | $41.2M | |
Current Portion Of Long-Term Debt | $13M | $17.2M | $3.3M | $21.3M | $3.3M | |
Current Portion Of Capital Lease Obligations | -- | -- | $6.9M | $7.1M | $7.2M | |
Other Current Liabilities | $6.4M | -- | -- | -- | -- | |
Total Current Liabilities | $93.9M | $115.2M | $86.9M | $86.2M | $71M | |
Long-Term Debt | $208.5M | $263.2M | $309.6M | $280M | $278.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $365.1M | $440.8M | $486.9M | $435.8M | $407M | |
Common Stock | $12K | $12K | $11K | $11K | $12K | |
Other Common Equity Adj | $2.4M | $370K | -$3.5M | -$3.5M | -$5.1M | |
Common Equity | $281.6M | $353.6M | $382.8M | $399.2M | $387.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $281.6M | $353.6M | $382.8M | $399.2M | $387.2M | |
Total Liabilities and Equity | $646.7M | $794.5M | $869.7M | $835M | $794.2M | |
Cash and Short Terms | $59.3M | $44M | $32.6M | $102.8M | $56.4M | |
Total Debt | $221.5M | $280.4M | $312.9M | $301.2M | $281.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $19.9M | $18.7M | $55M | $43.8M | $24M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $93M | $139M | $102.4M | $73.9M | $83.8M | |
Inventory | $74.1M | $140.1M | $149.6M | $95.2M | $86.9M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $5.7M | $11.6M | $6.6M | $7M | $8.4M | |
Total Current Assets | $194.8M | $313.4M | $318.7M | $221.3M | $211.5M | |
Property Plant And Equipment | $50.6M | $101.2M | $142.1M | $141.5M | $139.2M | |
Long-Term Investments | $25.5M | $23.9M | $25.1M | $26.3M | $25.8M | |
Goodwill | $115.6M | $129.6M | $131.2M | $131M | $154.7M | |
Other Intangibles | $283.6M | $331.6M | $302.3M | $275.9M | $289.2M | |
Other Long-Term Assets | -- | $4.6M | $2.4M | $5.3M | $3.4M | |
Total Assets | $675.1M | $914.9M | $929.7M | $808.6M | $824.6M | |
Accounts Payable | $40M | $55.8M | $48.8M | $25M | $28M | |
Accrued Expenses | $49.7M | $57.3M | $46.7M | $35.8M | $44.6M | |
Current Portion Of Long-Term Debt | $23M | $3.3M | $3.3M | $3.3M | $3.3M | |
Current Portion Of Capital Lease Obligations | -- | $6.8M | $7.1M | $6.8M | $7.1M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $113.7M | $124M | $106.3M | $70.9M | $83M | |
Long-Term Debt | $382.9M | $320.9M | $357.2M | $279.5M | $303.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $559.7M | $534.8M | $554.6M | $416.8M | $443.4M | |
Common Stock | $11K | $12K | $11K | $11K | $12K | |
Other Common Equity Adj | $1.2M | $1.6M | -$3.7M | -$4.4M | -$4.8M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $115.4M | $380.1M | $375M | $391.8M | $381.1M | |
Total Liabilities and Equity | $675.1M | $914.9M | $929.7M | $808.6M | $824.6M | |
Cash and Short Terms | $19.9M | $18.7M | $55M | $43.8M | $24M | |
Total Debt | $406M | $324.1M | $360.5M | $282.8M | $306.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $16M | -$62.3M | -$5.7M | -$2.4M | -$17.9M | |
Depreciation & Amoritzation | $25.4M | $32.2M | $38.2M | $40.8M | $44.4M | |
Stock-Based Compensation | $1.8M | $128.8M | $50.6M | $18.8M | $7.4M | |
Change in Accounts Receivable | $5.3M | -$25.7M | $10.7M | $14.4M | -$5.4M | |
Change in Inventories | -$17M | -$39.7M | -$57M | $68.2M | $22.7M | |
Cash From Operations | $63.2M | $33.7M | $32.3M | $116.4M | $61.3M | |
Capital Expenditures | $16.3M | $25M | $39.7M | $33.2M | $20.1M | |
Cash Acquisitions | -$100.1M | -$83.3M | -$5.4M | -- | -$64.5M | |
Cash From Investing | -$115.8M | -$108.2M | -$45M | -$31.7M | -$84.6M | |
Dividends Paid (Ex Special Dividend) | -- | -$110M | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $20M | $238.8M | $345.1M | $48M | -- | |
Long-Term Debt Repaid | -$24M | -$185.1M | -$311.4M | -$61.9M | -$22M | |
Repurchase of Common Stock | -$582K | -$281.6M | -$280.7M | -- | -- | |
Other Financing Activities | -$6.6M | -$1.3M | -$6.9M | -- | -- | |
Cash From Financing | $54.3M | $60M | $3.8M | -$13.9M | -$22M | |
Beginning Cash (CF) | $56.7M | $59.3M | $44M | $32.6M | $102.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.7M | -$14.5M | -$8.9M | $70.8M | -$45.4M | |
Ending Cash (CF) | $59.3M | $44M | $32.6M | $102.8M | $56.4M | |
Levered Free Cash Flow | $46.9M | $8.7M | -$7.4M | $83.2M | $41.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $8.5M | -$2.8M | -$14.4M | -$7.9M | -$6M | |
Depreciation & Amoritzation | $7.9M | $9.5M | $9.3M | $10.4M | $12.4M | |
Stock-Based Compensation | $1.5M | $16.9M | $6.8M | $1.2M | $2M | |
Change in Accounts Receivable | -$63.1M | -$79M | -$58.1M | -$45.3M | -$57.2M | |
Change in Inventories | -$9.2M | -$30.5M | $15.6M | $1.6M | -$9.6M | |
Cash From Operations | -$41M | -$57.5M | -$14.5M | -$34.5M | -$46.9M | |
Capital Expenditures | $4.6M | $6.7M | $9.9M | $5.3M | $3.5M | |
Cash Acquisitions | -- | -- | -- | -- | -$4.9M | |
Cash From Investing | -$4.6M | -$6.7M | -$9.9M | -$5.3M | -$8.4M | |
Dividends Paid (Ex Special Dividend) | -$110M | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $188.8M | $340.1M | $48M | -- | $25M | |
Long-Term Debt Repaid | -$5.8M | -$294M | -$914K | -$19M | -$201K | |
Repurchase of Common Stock | -$64.9M | -$257.7M | -- | -- | -$2.3M | |
Other Financing Activities | -$2M | -$6.9M | -- | -- | -- | |
Cash From Financing | $6.1M | $39.3M | $47.1M | -$19M | $22.5M | |
Beginning Cash (CF) | $59.3M | $44M | $32.6M | $102.8M | $56.4M | |
Foreign Exchange Rate Adjustment | $207K | -$411K | -$278K | -$93K | $343K | |
Additions / Reductions | -$39.6M | -$24.9M | $22.7M | -$58.9M | -$32.8M | |
Ending Cash (CF) | $19.9M | $18.7M | $55M | $43.8M | $24M | |
Levered Free Cash Flow | -$45.7M | -$64.1M | -$24.4M | -$39.9M | -$50.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $40M | -$73.7M | -$17.2M | $4.1M | -$16M | |
Depreciation & Amoritzation | $27.5M | $33.8M | $37.9M | $41.9M | $46.5M | |
Stock-Based Compensation | $3.1M | $144.2M | $40.5M | $13.3M | $8.1M | |
Change in Accounts Receivable | -$41.6M | -$41.6M | $31.6M | $27.2M | -$17.2M | |
Change in Inventories | -$15.3M | -$60.9M | -$10.9M | $54.2M | $11.5M | |
Cash From Operations | $48.4M | $17.3M | $75.3M | $96.3M | $48.9M | |
Capital Expenditures | $18.1M | $27M | $43M | $28.6M | $18.2M | |
Cash Acquisitions | -$100.1M | -$83.3M | -$5.4M | -- | -$69.5M | |
Cash From Investing | -$117.6M | -$110.3M | -$48.3M | -$27.1M | -$87.7M | |
Dividends Paid (Ex Special Dividend) | -$109.6M | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $203.8M | $390.1M | $53M | -- | $25M | |
Long-Term Debt Repaid | -$29.8M | -$473.4M | -$18.4M | -$80M | -$3.2M | |
Repurchase of Common Stock | -$65.5M | -$474.4M | -- | -- | -- | |
Other Financing Activities | -- | -$6.1M | -- | -- | -- | |
Cash From Financing | $55.8M | $93.2M | $11.6M | -$80M | $19.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$13.4M | $192K | $38.6M | -$10.8M | -$19.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $30.3M | -$9.8M | $32.3M | $67.7M | $30.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $8.5M | -$2.8M | -$14.4M | -$7.9M | -$6M | |
Depreciation & Amoritzation | $7.9M | $9.5M | $9.3M | $10.4M | $12.4M | |
Stock-Based Compensation | $1.5M | $16.9M | $6.8M | $1.2M | $2M | |
Change in Accounts Receivable | -$63.1M | -$79M | -$58.1M | -$45.3M | -$57.2M | |
Change in Inventories | -$9.2M | -$30.5M | $15.6M | $1.6M | -$9.6M | |
Cash From Operations | -$41M | -$57.5M | -$14.5M | -$34.5M | -$46.9M | |
Capital Expenditures | $4.6M | $6.7M | $9.9M | $5.3M | $3.5M | |
Cash Acquisitions | -- | -- | -- | -- | -$4.9M | |
Cash From Investing | -$4.6M | -$6.7M | -$9.9M | -$5.3M | -$8.4M | |
Dividends Paid (Ex Special Dividend) | -$110M | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $188.8M | $340.1M | $48M | -- | $25M | |
Long-Term Debt Repaid | -$5.8M | -$294M | -$914K | -$19M | -$201K | |
Repurchase of Common Stock | -$64.9M | -$257.7M | -- | -- | -$2.3M | |
Other Financing Activities | -$2M | -$6.9M | -- | -- | -- | |
Cash From Financing | $6.1M | $39.3M | $47.1M | -$19M | $22.5M | |
Beginning Cash (CF) | $59.3M | $44M | $32.6M | $102.8M | $56.4M | |
Foreign Exchange Rate Adjustment | $207K | -$411K | -$278K | -$93K | $343K | |
Additions / Reductions | -$39.6M | -$24.9M | $22.7M | -$58.9M | -$32.8M | |
Ending Cash (CF) | $19.9M | $18.7M | $55M | $43.8M | $24M | |
Levered Free Cash Flow | -$45.7M | -$64.1M | -$24.4M | -$39.9M | -$50.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.